|
Del Pozo-Valero M, Corton M, Lopez-Rodriguez R, Mahillo-Fernandez I, Ruiz-Hornillos J, Minguez P, Villaverde C, Perez-Tomas ME, Barreda-Sanchez M, Mancebo E; STOP_Coronavirus Study Group; Paz-Artal E, Guillen-Navarro E, Almoguera B, Ayuso C. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years. Geroscience. 2023 Feb;45(1):543-553. doi: 10.1007/s11357-022-00666-5. Epub 2022 Oct 3. PubMed PMID: 36184726; PubMed Central PMCID: PMC9527133.
AÑO: 2023; IF: 5.3
|
36184726
|
Sojo-Dorado J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, Merino de Lucas E, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jimenez V, Docobo-Perez F, Pascual A, Rodriguez-Bano J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. PubMed PMID: 37260299; PubMed Central PMCID: PMC10775153.
AÑO: 2023; IF: 3.9
|
|
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo A, Diaz-Pena R; Scourge Cohort Group. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. HLA. 2023 Dec;102(6):731-739. doi: 10.1111/tan.15160. Epub 2023 Aug 1. PubMed PMID: 37528566.
AÑO: 2023; IF: 5.9
|
|
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enriquez-Gomez A, Munoz P, Plata-Ciezar A, Miro JM, Alarcon A, Martinez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vazquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. PubMed PMID: 37442488.
AÑO: 2023; IF: 4.9
|
|
Escrihuela-Vidal F, Berbel D, Fernandez-Hidalgo N, Escola-Verge L, Munoz P, Olmedo M, Goenaga MA, Goikoetxea J, Farinas MC, De Alarcon A, Miro JM, Ojeda G, Plata A, Cuervo G, Carratala J; GAMES Investigators. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. Clin Infect Dis. 2023 Nov 11;77(9):1273-1281. doi: 10.1093/cid/ciad375. PubMed PMID: 37345869.
AÑO: 2023; IF: 8.2
|